⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13208843 | 1.00 | — | — | |
| SCHEMBL5865632 | 0.76 | SLC22A6 (0.50) | — | |
| SCHEMBL7383379 | 0.76 | LMNA (0.39) | — | |
| SCHEMBL636401 | 0.76 | — | — | |
| SCHEMBL542867 | 0.76 | — | — | |
| SCHEMBL23130146 | 0.75 | — | — | |
| Bromide SCHEMBL1086994 | 0.73 | ALOX15 (0.37) | — | |
| SCHEMBL338756 | 0.73 | — | — | |
| SCHEMBL447923 | 0.73 | — | — | |
| SCHEMBL12085019 | 0.72 | LMNA (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114437250-B | Chitosan oligosaccharide amino hydroxy propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2023-07-04 | — | — | CN | claimed |
| CN-114437250-A | Chitosan oligosaccharide amino hydroxyl propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2022-05-06 | — | — | CN | claimed |
| CN-114437250-B | Chitosan oligosaccharide amino hydroxy propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-114437250-B | Chitosan oligosaccharide amino hydroxy propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-114437250-B | Chitosan oligosaccharide amino hydroxy propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-114437250-A | Chitosan oligosaccharide amino hydroxyl propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2022-05-06 | — | — | CN | disclosed |
| CN-114437250-A | Chitosan oligosaccharide amino hydroxyl propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2022-05-06 | — | — | CN | disclosed |
| CN-114437250-A | Chitosan oligosaccharide amino hydroxyl propionamide derivative and preparation method thereof | 内蒙古农业大学 | 2022-05-06 | — | — | CN | disclosed |
| US-20160303243-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES LLC (US) | 2016-10-20 | — | — | US | disclosed |
| US-9346845-B2 | Anionic conjugates of glycosylated bacterial metabolite | GLYCAN BIOSCIENCES LLC (US) | 2016-05-24 | — | — | US | disclosed |
| EP-2933875-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, DYE-ABSORBED ELECTRODE, AND METHOD FOR MANUFACTURING DYE-SENSITIZED SOLAR CELL | Fujifilm Corporation (JP) | 2015-10-21 | — | — | EP | disclosed |
| US-20100304430-A1 | Methods for Generating Analogs of Coenzyme A | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-12-02 | — | — | US | disclosed |
| US-7727738-B2 | Methods for generating analogs of coenzyme A | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-06-01 | — | — | US | disclosed |
| WO-2008016643-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | CYTOKINETICS, INCORPORATED (US) | 2008-02-07 | — | — | WO | disclosed |
| EP-1876168-A1 | Method for manufacturing beta amino alpha hydroxy carboxylic acid amides | Evonik Degussa GmbH (DE) | 2008-01-09 | — | — | EP | disclosed |
| CN-101087601-A | Compounds for inhibiting copper-containing amine oxidases and uses thereof | GENMEDICA THERAPEUTICS SL (ES) | 2007-12-12 | — | — | CN | disclosed |
| US-20070128683-A1 | Metabolic delivery of coenzyme A analogs | NATIONAL SCIENCE FOUNDATION | 2007-06-07 | — | — | US | disclosed |
| EP-1411949-A4 | 8/17 HETEROCYCLIC COMPOUNDS AND USES THEREOF AS D-ALANYL-D-ALANINE LIGASE INHIBITORS | ESSENTIAL THERAPEUTICS INC (US) | 2004-11-24 | — | — | EP | disclosed |
| EP-1411949-A2 | 8/17 HETEROCYCLIC COMPOUNDS AND USES THEREOF AS D-ALANYL-D-ALANINE LIGASE INHIBITORS | Essential Therapeutics, Inc. (US) | 2004-04-28 | — | — | EP | disclosed |
| WO-2003001887-A2 | FUSED PYRIMIDINES AS D-ALANYL-D-ALANINE LIGASE INHIBITORS | ESSENTIAL THERAPEUTICS, INC. (US) | 2003-01-09 | — | — | WO | disclosed |